Capromorelin Tartrate – Solution, 600mg (20mg/mL)

Capromorelin Tartrate – Solution, 600mg (20mg/mL)

This premium, laboratory-grade research compound delivers ultra-pure Capromorelin Tartrate solution at 20mg/mL concentration, representing the highest standard for modern scientific investigations into growth hormone secretagogue receptor activation and ghrelin mimetic signaling mechanisms. The ready-to-use solution format eliminates preparation time and ensures precise dosing accuracy for in vivo animal studies, eliminating solubility variability and providing investigators with a validated vehicle system ideal for analytical testing, pharmacokinetic modeling, and in vivo preclinical research applications where precise capromorelin administration is critical for studying GH/IGF-1 augmentation and metabolic regulation.

All shipments to the 50 United States are fulfilled directly from primary U.S. production facilities, ensuring 2-5 business day delivery nationwide. International orders to the United Kingdom and continental Europe are processed through our dedicated United Kingdom shipping hub, which streamlines customs clearance and reduces transit times across all European countries. This dual-hub logistics infrastructure guarantees seamless, compliant delivery while maintaining chemical integrity throughout transit.

• Public third-party lab reports with unique lot-coding ensure absolute transparency for every batch sold

• Formulation contains zero adulterants, excipients, flow agents, or contaminants—pure Capromorelin Tartrate solution only

• Strategic over-fill compensates for solution adhesion loss, guaranteeing minimum 30mL (600mg) recoverable volume

• Amber glass vial features UV-resistant construction and tamper-proof seal for transit safety

Technical Specifications & Chemical Profile

Research Applications & Storage Protocols

GHS-R1a Agonism & Growth Hormone/IGF-1 Secretion Profiling

Capromorelin Tartrate (formerly CP-424391) functions as a potent, orally active growth hormone secretagogue and ghrelin mimetic that acts as a high-affinity agonist of the growth hormone secretagogue receptor 1a (GHS-R1a), also known as the ghrelin receptor, with a Ki of 7 nM for human GHS-R1a and an EC₅₀ of 3 nM in rat pituitary cells for inducing growth hormone secretion. The compound directly increases growth hormone (GH) and insulin growth factor-1 (IGF-1) secretion through GHS-R1a activation, demonstrating structural homology with pyrazolinone-piperidine dipeptides that confers potent ghrelin receptor agonist activity. Capromorelin increases gastric motility and has been studied recently in patients with spinal cord injuries, demonstrating broader metabolic effects beyond GH/IGF-1 augmentation. In human clinical trials, capromorelin tartrate has been used as a treatment for frailty in elderly adults, showing potential for addressing age-related muscle weakness and metabolic decline. Capromorelin is indicated for appetite stimulation in dogs and increases food consumption and body weight when administered orally to healthy adult Beagle dogs, demonstrating its efficacy in veterinary appetite disorder treatment. Formulations containing capromorelin have been used clinically for treating weight loss in cats with chronic kidney disease and as an appetite stimulant in dogs, with the veterinary medicinal product ENTYCE® (capromorelin oral solution) approved for increasing serum glucose levels in cats. This GHS-R1a agonist mechanism positions Capromorelin Tartrate solution as a critical tool compound for investigating frailty mechanisms in elderly populations, appetite stimulation research, weight loss disorder models, chronic kidney disease studies, spinal cord injury recovery pathways, and gastric motility regulation in preclinical models, offering potential therapeutic benefits for metabolic and muscle health without ghrelin-related side effects.

Handling & Storage Guidelines

• Long-Term Storage: Store at room temperature (15-25°C) in airtight conditions; protect from light and excessive heat; solution remains stable for 12-24 months from manufacture date when stored properly in amber glass; water solubility: 20 mg/mL (clear)

• Solubility: Pre-dissolved formulation ready for direct use; H₂O: 20 mg/mL (clear); DMSO: >5 mg/mL; PEG300/Tween80 formulations for in vivo studies available

• Appearance: Clear colorless to pale yellow liquid solution; 30mL volume containing 600mg total Capromorelin Tartrate at 20mg/mL concentration

Global Logistics & Order Fulfillment

We proudly support scientific advancement across all 50 U.S. states and throughout Europe. Customers can seamlessly toggle their preferred currency between USD and EUR using the currency switcher located on the left-hand side of our website. All shipments are securely packaged to withstand international transit without compromising structural or chemical stability.

Laboratory Use Only Disclaimer

This material is sold strictly for laboratory research and development use only. It is not approved for human consumption, nor for medical, veterinary, or household applications. All purchases are governed by our standard Terms & Conditions. Please review them carefully before placing your order.